Press Releases from Lysosomal Storage Disorder (LSD) Therapeutics- Pharma Proff (1 total)
Lysosomal Storage Disorder (LSD) Therapeutics Pipeline to Witness Remarkable Gro …
LSD refers to a group of genetically inherited disorders, which are characterized by enzyme deficiencies. It results in accumulation of toxic chemical substances in the body’s cells. This group of disorders consists of approximately 50 diseases, including Metachromatic leukodystrophy; Mucolipidosis types I, II/III, and IV; Mucopolysaccharide storage disease; Gaucher disease; Niemann-Pick disease type C (NPC); Schindler disease types I and II; Tay Sachs disease; Pompe disease; and Sandhoff disease. These…
